Cooper Cos. (COO): Price and Financial Metrics
COO Price/Volume Stats
Current price | $368.20 | 52-week high | $395.20 |
Prev. close | $369.39 | 52-week low | $244.21 |
Day low | $365.85 | Volume | 424,900 |
Day high | $369.85 | Avg. volume | 288,264 |
50-day MA | $375.22 | Dividend yield | 0.02% |
200-day MA | $327.93 | Market Cap | 18.21B |
COO Stock Price Chart Interactive Chart >
COO POWR Grades
- Stability is the dimension where COO ranks best; there it ranks ahead of 75.85% of US stocks.
- The strongest trend for COO is in Stability, which has been heading up over the past 179 days.
- COO ranks lowest in Momentum; there it ranks in the 15th percentile.
COO Stock Summary
- COO has a higher market value than 89.56% of US stocks; more precisely, its current market capitalization is $18,692,757,322.
- With a one year PEG ratio of 449.56, COOPER COMPANIES INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.38% of US stocks.
- COO's went public 37.42 years ago, making it older than 93.61% of listed US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to COOPER COMPANIES INC, a group of peers worth examining would be JHX, CSL, CPB, PPG, and NVT.
- COO's SEC filings can be seen here. And to visit COOPER COMPANIES INC's official web site, go to www.coopercos.com.
COO Valuation Summary
- COO's price/sales ratio is 5.6; this is 154.55% higher than that of the median Healthcare stock.
- Over the past 243 months, COO's EV/EBIT ratio has gone up 23.4.
Below are key valuation metrics over time for COO.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
COO | 2023-05-23 | 5.6 | 2.6 | 50.1 | 38.7 |
COO | 2023-05-22 | 5.7 | 2.6 | 51.4 | 39.6 |
COO | 2023-05-19 | 5.6 | 2.6 | 50.9 | 39.2 |
COO | 2023-05-18 | 5.7 | 2.6 | 51.1 | 39.4 |
COO | 2023-05-17 | 5.6 | 2.6 | 50.8 | 39.2 |
COO | 2023-05-16 | 5.7 | 2.6 | 51.1 | 39.4 |
COO Growth Metrics
- The 5 year net cashflow from operations growth rate now stands at -1.82%.
- Its 4 year net income to common stockholders growth rate is now at 4.24%.
- Its 3 year net income to common stockholders growth rate is now at 121.96%.

The table below shows COO's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 3,308.4 | 692.4 | 385.8 |
2022-06-30 | 3,219.5 | 736.2 | 430.6 |
2022-03-31 | 3,139.5 | 696.1 | 948 |
2021-12-31 | 3,029.2 | 756.9 | 938.9 |
2021-09-30 | 2,922.5 | 738.6 | 2,944.7 |
2021-06-30 | 2,845 | 782.4 | 2,915.6 |
COO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- COO has a Quality Grade of C, ranking ahead of 72.46% of graded US stocks.
- COO's asset turnover comes in at 0.332 -- ranking 126th of 186 Medical Equipment stocks.
- KRMD, XENT, and BIOL are the stocks whose asset turnover ratios are most correlated with COO.
The table below shows COO's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-31 | 0.332 | 0.660 | 0.087 |
2021-04-30 | 0.339 | 0.648 | 0.093 |
2021-01-31 | 0.341 | 0.632 | 0.077 |
2020-10-31 | 0.366 | 0.631 | 0.079 |
2020-07-31 | 0.374 | 0.641 | 0.096 |
2020-04-30 | 0.399 | 0.651 | 0.122 |
COO Price Target
For more insight on analysts targets of COO, see our COO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $478.50 | Average Broker Recommendation | 1.63 (Moderate Buy) |
Cooper Cos. (COO) Company Bio
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company, publicly traded on the NYSE (NYSE:COO). With its headquarters in San Ramon, California, it has a workforce of more than 12,000 employees and consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI) which manufactures medical devices and fertility and genomic products for the women’s health care market. (Source:Wikipedia)
Latest COO News From Around the Web
Below are the latest news stories about COOPER COMPANIES INC that investors may wish to consider to help them evaluate COO as an investment opportunity.
XRAY vs. COO: Which Stock Is the Better Value Option?XRAY vs. COO: Which Stock Is the Better Value Option? |
The Cooper Companies (COO) Shares Rose on Strong Organic Growth OutlookBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The first quarter was difficult for the fund, as it failed to participate in the broader market rally and declined 3.69% compared to the 3.27% decline for the benchmark Russell […] |
CooperSurgical® and Ostro Named Best Patient Education Solution in the 7th Annual MedTech Breakthrough AwardsCooperSurgical, a global leader in women's healthcare, and Ostro, a healthcare engagement platform for consumers and healthcare providers, have been selected as "Best Patient Education Solution" in the 7th annual MedTech Breakthrough Awards. This year over 4,000 of the top companies, technologies, and products in the global health and medical technology market from over 17 different countries competed. |
Why You Should Buy The Cooper Companies (COO) Stock NowThe Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further. |
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Misses Revenue EstimatesAnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of -51.92% and 65.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
COO Price Returns
1-mo | -4.06% |
3-mo | 12.30% |
6-mo | 14.24% |
1-year | 5.00% |
3-year | 16.22% |
5-year | 61.56% |
YTD | 11.36% |
2022 | -21.06% |
2021 | 15.33% |
2020 | 13.10% |
2019 | 26.27% |
2018 | 16.84% |
COO Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching COO
Want to see what other sources are saying about Cooper Companies Inc's financials and stock price? Try the links below:Cooper Companies Inc (COO) Stock Price | Nasdaq
Cooper Companies Inc (COO) Stock Quote, History and News - Yahoo Finance
Cooper Companies Inc (COO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...